@article{716ee6e8771d4842ac197cb260fb5beb,
title = "Conceptual framework for addressing residual atherosclerotic cardiovascular disease risk in the era of precision medicine",
keywords = "atherosclerosis, biomarkers, precision medicine, residual risk, secondary prevention",
author = "Patel, {Kershaw V.} and Ambarish Pandey and {de Lemos}, {James A}",
note = "Funding Information: Dr de Lemos has received grant support from Abbott Diagnostics; consulting income from Abbott Diagnostics, Ortho Clinical Diagnostics, Quidel Cardiovascular, and Roche Diagnostics; fees for participation on data safety and monitoring boards from Novo Nordisc and Regeneron; and fees for participating on a steering committee from Amgen. The other authors report no conflicts of interest.",
year = "2018",
month = jun,
day = "12",
doi = "10.1161/CIRCULATIONAHA.118.035289",
language = "English (US)",
volume = "137",
pages = "2551--2553",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "24",
}